Head-to-head · WeighScore
LevelsRx vs TeleClinic
The verdict
LevelsRx takes it — 66.3/100 to 60.8/100.
LevelsRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LevelsRx is a US direct-to-consumer telehealth offering compounded GLP-1 weight-loss medication, including compounded semaglutide (injectable and an oral liposomal liquid) starting at 150 dollars per month…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | LevelsRx | TeleClinic |
|---|---|---|
| WeighScore | 66.3/100 | 60.8/100 |
| Grade | C | C |
| Scorecard rank | #196 | #314 |
| Semaglutide | $150/mo (starting dose, compounded) | $199/mo (compounded) |
| Tirzepatide | $240/mo (starting dose, compounded) | $299/mo (compounded) |
| Coverage | Coverage not published | 47 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #196 · C
Strengths
- Both injectable and oral semaglutide plus tirzepatide, with same-day virtual visits
- Weight-loss money-back warranty if targets are not met
- 24-7 phone and email support with unlimited online provider visits
Where it loses points
- Compounding pharmacy is not named publicly
- States served are not published on the site
- Prices are 'starting at' figures that may rise with dose
Graded #314 · C
Strengths
- Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
- LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
- Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing
Where it loses points
- Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
- Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
- Not available in California, South Carolina, or New Jersey
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.